{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T05:06:42Z","timestamp":1774069602945,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Knight\u2019s Templar Eye Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ejpb.2018.09.003","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T03:56:14Z","timestamp":1536292574000},"page":"37-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Modeling of nanoparticle transport through the female reproductive tract for the treatment of infectious diseases"],"prefix":"10.1016","volume":"138","author":[{"given":"Lee B.","family":"Sims","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hunter A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Halwes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill M.","family":"Steinbach-Rankins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann B.","family":"Frieboes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejpb.2018.09.003_b0005","doi-asserted-by":"crossref","first-page":"e74404","DOI":"10.1371\/journal.pone.0074404","article-title":"Multicompartmental pharmacokinetic model of tenofovir delivery by a vaginal gel","volume":"8","author":"Gao","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ejpb.2018.09.003_b0010","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.xphs.2016.02.015","article-title":"Sensitivity analysis of a pharmacokinetic model of vaginal anti-HIV microbicide drug delivery","volume":"105","author":"Jarrett","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2018.09.003_b0015","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/ajpa.22896","article-title":"A mixed model for the relationship between climate and human cranial form","volume":"160","author":"Katz","year":"2016","journal-title":"Am. J. Phys. Anthropol."},{"issue":"2","key":"10.1016\/j.ejpb.2018.09.003_b0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.addr.2008.09.006","article-title":"Mathematical modeling of molecular diffusion through mucus","volume":"61","author":"Cu","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"46","key":"10.1016\/j.ejpb.2018.09.003_b0025","doi-asserted-by":"crossref","first-page":"19268","DOI":"10.1073\/pnas.0905998106","article-title":"Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier","volume":"106","author":"Tang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.ejpb.2018.09.003_b0030","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1021\/acsnano.5b03876","article-title":"Impact of surface polyethylene glycol (PEG) density on biodegradable nanoparticle transport in mucus ex vivo and distribution in vivo","volume":"9","author":"Xu","year":"2015","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.ejpb.2018.09.003_b0035","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/anie.201006849","article-title":"Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus","volume":"50","author":"Yang","year":"2011","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejpb.2018.09.003_b0040","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jconrel.2014.07.045","article-title":"Nanoparticle penetration of human cervicovaginal mucus: the effect of polyvinyl alcohol","volume":"192","author":"Yang","year":"2014","journal-title":"J. Control Release"},{"issue":"3","key":"10.1016\/j.ejpb.2018.09.003_b0045","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s13346-015-0227-1","article-title":"Vaginal deployment and tenofovir delivery by microbicide gels","volume":"5","author":"Gao","year":"2015","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2018.09.003_b0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.addr.2014.12.004","article-title":"Polymer-based nanocarriers for vaginal drug delivery","volume":"92","author":"das Neves","year":"2015","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"12","key":"10.1016\/j.ejpb.2018.09.003_b0055","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2174\/1381612820666141029150427","article-title":"Nano-sized platforms for vaginal drug delivery","volume":"21","author":"El-Hammadi","year":"2015","journal-title":"Curr. Pharm. Des."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2018.09.003_b0060","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijpharm.2012.12.031","article-title":"Encapsulation of Acyclovir in new carboxylated cyclodextrin-based nanosponges improves the agent's antiviral efficacy","volume":"443","author":"Lembo","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.ejpb.2018.09.003_b0065","doi-asserted-by":"crossref","first-page":"7680","DOI":"10.1128\/AAC.01819-15","article-title":"Impact of hydroxychloroquine-loaded polyurethane intravaginal rings on lactobacilli","volume":"59","author":"Traore","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl 1","key":"10.1016\/j.ejpb.2018.09.003_b0070","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.antiviral.2010.09.006","article-title":"Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines","volume":"88","author":"Whaley","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ejpb.2018.09.003_b0075","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jconrel.2014.04.033","article-title":"Nanoparticle-based drug delivery to the vagina: a review","volume":"190","author":"Ensign","year":"2014","journal-title":"J. Control Release"},{"issue":"3","key":"10.1016\/j.ejpb.2018.09.003_b0080","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00018-014-1756-3","article-title":"Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs","volume":"72","author":"Steinbach","year":"2015","journal-title":"Cell Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2018.09.003_b0085","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1021\/mp8001254","article-title":"Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus","volume":"6","author":"Cu","year":"2009","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2018.09.003_b0090","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2018.09.003_b0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jconrel.2016.09.020","article-title":"Nanoparticles-in-film for the combined vaginal delivery of anti-HIV microbicide drugs","volume":"243","author":"Cunha-Reis","year":"2016","journal-title":"J. Control Release"},{"issue":"6","key":"10.1016\/j.ejpb.2018.09.003_b0100","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nmat2444","article-title":"Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA","volume":"8","author":"Woodrow","year":"2009","journal-title":"Nat. Mater."},{"issue":"2","key":"10.1016\/j.ejpb.2018.09.003_b0105","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jconrel.2011.06.036","article-title":"In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery","volume":"156","author":"Cu","year":"2011","journal-title":"J. Control. Release"},{"issue":"138","key":"10.1016\/j.ejpb.2018.09.003_b0110","doi-asserted-by":"crossref","first-page":"p. 138ra79","DOI":"10.1126\/scitranslmed.3003453","article-title":"Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus","volume":"4","author":"Ensign","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"28","key":"10.1016\/j.ejpb.2018.09.003_b0115","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/adma.201201800","article-title":"Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery","volume":"24","author":"Ensign","year":"2012","journal-title":"Adv. Mater."},{"issue":"5","key":"10.1016\/j.ejpb.2018.09.003_b0120","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1073\/pnas.0608611104","article-title":"Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus","volume":"104","author":"Lai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Pt A","key":"10.1016\/j.ejpb.2018.09.003_b0125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2018.09.003_b0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.addr.2015.02.001","article-title":"Mucoadhesive and thermogelling systems for vaginal drug delivery","volume":"92","author":"Caramella","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.ejpb.2018.09.003_b0135","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/wnan.144","article-title":"Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?","volume":"3","author":"das Neves","year":"2011","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"9","key":"10.1016\/j.ejpb.2018.09.003_b0140","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1517\/17425247.2014.924499","article-title":"Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development","volume":"11","author":"Wong","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"issue":"11","key":"10.1016\/j.ejpb.2018.09.003_b0145","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1073\/pnas.1012861108","article-title":"Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection","volume":"108","author":"Li","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.ejpb.2018.09.003_b0150","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1208\/s12249-012-9837-9","article-title":"Development and evaluation of an in vitro vaginal model for assessment of drug's biopharmaceutical properties: curcumin","volume":"13","author":"Berginc","year":"2012","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"10.1016\/j.ejpb.2018.09.003_b0155","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.3109\/10717544.2016.1153749","article-title":"A vaginal drug delivery model","volume":"23","author":"Mirza","year":"2016","journal-title":"Drug Deliv."},{"issue":"3","key":"10.1016\/j.ejpb.2018.09.003_b0160","doi-asserted-by":"crossref","first-page":"594a","DOI":"10.1016\/j.bpj.2011.11.3239","article-title":"Multi-compartmental transport of anti-HIV molecules into and through mucosa","volume":"102","author":"Katz","year":"2012","journal-title":"Biophys. J ."},{"key":"10.1016\/j.ejpb.2018.09.003_b0165","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2015.04.017","article-title":"Vaginal drug distribution modeling","volume":"92","author":"Katz","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.ejpb.2018.09.003_b0170","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1002\/jps.22120","article-title":"Compartmental transport model of microbicide delivery by an intravaginal ring","volume":"99","author":"Geonnotti","year":"2010","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2018.09.003_b0175","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1021\/acs.molpharmaceut.7b01089","article-title":"Computational modeling of antiviral drug diffusion from poly(lactic- co-glycolic-acid) fibers and multicompartment pharmacokinetics for application to the female reproductive tract","volume":"15","author":"Halwes","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2018.09.003_b0180","doi-asserted-by":"crossref","DOI":"10.1002\/0471143030.cb2613s52","article-title":"A dual-chamber model of the female genital tract to evaluate epithelial toxicity of candidate anti-HIV microbicides","author":"Arien","year":"2011","journal-title":"Curr. Protoc. Cell Biol."},{"key":"10.1016\/j.ejpb.2018.09.003_b0185","first-page":"497","article-title":"In vitro placental model optimization for nanoparticle transport studies","volume":"7","author":"Cartwright","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"8","key":"10.1016\/j.ejpb.2018.09.003_b0190","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1021\/acs.molpharmaceut.5b00073","article-title":"Biodegradable film for the targeted delivery of siRNA-loaded nanoparticles to vaginal immune cells","volume":"12","author":"Gu","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2018.09.003_b0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12951-016-0185-x","article-title":"Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer","volume":"14","author":"Sims","year":"2016","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.ejpb.2018.09.003_b0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12951-017-0298-x","article-title":"Distribution of PLGA-modified nanoparticles in 3D cell culture models of hypo-vascularized tumor tissue","volume":"15","author":"Sims","year":"2017","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejpb.2018.09.003_b0205","first-page":"1345","article-title":"Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content","volume":"7","author":"Li","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"11","key":"10.1016\/j.ejpb.2018.09.003_b0210","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.1021\/nn1018818","article-title":"Physiologically based pharmacokinetic modeling of nanoparticles","volume":"4","author":"Lu","year":"2010","journal-title":"Acs Nano"},{"issue":"11","key":"10.1016\/j.ejpb.2018.09.003_b0215","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2217\/nnm-2016-0047","article-title":"Nanoparticles coated with high molecular weight PEG penetrate mucus and provide uniform vaginal and colorectal distribution in vivo","volume":"11","author":"Maisel","year":"2016","journal-title":"Nanomedicine (Lond)"},{"issue":"3","key":"10.1016\/j.ejpb.2018.09.003_b0220","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jconrel.2011.08.032","article-title":"A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles","volume":"157","author":"Mert","year":"2012","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejpb.2018.09.003_b0225","first-page":"2(2)","article-title":"Biodegradable mucus-penetrating nanoparticles composed of diblock copolymers of polyethylene glycol and poly(lactic-co-glycolic acid).","author":"Yu","year":"2012","journal-title":"Drug Deliv. Transl. Res."},{"issue":"11","key":"10.1016\/j.ejpb.2018.09.003_b0230","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1021\/acs.molpharmaceut.5b00426","article-title":"Effects of doxorubicin delivery systems and mild hyperthermia on tissue penetration in 3D cell culture models of ovarian cancer residual disease","volume":"12","author":"Eetezadi","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2018.09.003_b0235","first-page":"3603","article-title":"Enhanced penetration into 3D cell culture using two and three layered gold nanoparticles","volume":"8","author":"England","year":"2013","journal-title":"Int. J. Nanomed."},{"issue":"16","key":"10.1016\/j.ejpb.2018.09.003_b0240","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1016\/j.biomaterials.2013.02.014","article-title":"Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides","volume":"34","author":"Gao","year":"2013","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.ejpb.2018.09.003_b0245","article-title":"Evaluation of anti-HER2 scFv-conjugated PLGA-PEG nanoparticles on 3D tumor spheroids of BT474 and HCT116 cancer cells","volume":"7","author":"Le","year":"2016","journal-title":"Adv. Natural Sci.-Nanosci. Nanotechnol."},{"issue":"2","key":"10.1016\/j.ejpb.2018.09.003_b0250","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1073\/pnas.0911748107","article-title":"Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses","volume":"107","author":"Lai","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.ejpb.2018.09.003_b0255","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.addr.2013.01.003","article-title":"In vitro and in vivo models for the study of oral delivery of nanoparticles","volume":"65","author":"Gamboa","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"28","key":"10.1016\/j.ejpb.2018.09.003_b0260","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1016\/j.biomaterials.2013.05.039","article-title":"Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake","volume":"34","author":"Ensign","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2018.09.003_b0265","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-60761-657-3_4","article-title":"Progress in siRNA delivery using multifunctional nanoparticles","volume":"629","author":"Gao","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejpb.2018.09.003_b0270","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.colsurfb.2017.07.038","article-title":"Recent applications of PLGA based nanostructures in drug delivery","volume":"159","author":"Mir","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejpb.2018.09.003_b0275","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2741\/e398","article-title":"Recent developments in multifunctional hybrid nanoparticles: opportunities and challenges in cancer therapy","volume":"4","author":"Salvador-Morales","year":"2012","journal-title":"Front. Biosci. (Elite Ed)"},{"issue":"1","key":"10.1016\/j.ejpb.2018.09.003_b0280","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijpharm.2017.08.084","article-title":"Engineering PLGA nano-based systems through understanding the influence of nanoparticle properties and cell-penetrating peptides for cochlear drug delivery","volume":"532","author":"Cai","year":"2017","journal-title":"Int. J. Pharm"},{"issue":"26","key":"10.1016\/j.ejpb.2018.09.003_b0285","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1016\/j.biomaterials.2011.04.053","article-title":"Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides","volume":"32","author":"Cheng","year":"2011","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.ejpb.2018.09.003_b0290","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.biomaterials.2011.09.061","article-title":"Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors","volume":"33","author":"Zhou","year":"2012","journal-title":"Biomaterials"},{"issue":"34","key":"10.1016\/j.ejpb.2018.09.003_b0295","doi-asserted-by":"crossref","first-page":"9343","DOI":"10.1016\/j.biomaterials.2014.07.043","article-title":"Multi-layered nanoparticles for combination gene and drug delivery to tumors","volume":"35","author":"Ediriwickrema","year":"2014","journal-title":"Biomaterials"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118306349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118306349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T19:39:41Z","timestamp":1555529981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641118306349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":59,"alternative-id":["S0939641118306349"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.09.003","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling of nanoparticle transport through the female reproductive tract for the treatment of infectious diseases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}